{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:08:47Z","timestamp":1790003327007,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL055798"],"award-info":[{"award-number":["HL055798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL088093"],"award-info":[{"award-number":["HL088093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Interleukin Genetics Inc."},{"name":"Guerbet LLC"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jacc.2013.12.030","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T16:31:01Z","timestamp":1392222661000},"page":"1724-1734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Pro-Inflammatory Interleukin-1 Genotypes Potentiate the Risk of Coronary Artery Disease and Cardiovascular Events Mediated by Oxidized Phospholipids and Lipoprotein(a)"],"prefix":"10.1016","volume":"63","author":[{"given":"Sotirios","family":"Tsimikas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon W.","family":"Duff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rogus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Huttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Clopton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Brilakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Kornman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Witztum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2013.12.030_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2013.12.030_bib2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(89)90134-7","article-title":"Peptide regulatory factors in non-malignant disease","volume":"1","author":"Duff","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2013.12.030_bib3","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.108.772491","article-title":"Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist","volume":"117","author":"Fearon","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.12.030_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacc.2013.12.030_bib5","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1301\/nr.2007.dec.S177-S181","article-title":"Influence of genetics on disease susceptibility and progression","volume":"65","author":"Duff","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jacc.2013.12.030_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/hmg\/ddi469","article-title":"Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context","volume":"15","author":"Chen","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacc.2013.12.030_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/cyto.2001.0974","article-title":"C-reactive protein levels are influenced by common IL-1 gene variations","volume":"17","author":"Berger","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.jacc.2013.12.030_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.ATV.0000150039.60906.02","article-title":"Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in\u00a0vitro","volume":"25","author":"Iacoviello","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2013.12.030_bib9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/ATVBAHA.108.167437","article-title":"Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation","volume":"28","author":"Reiner","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2013.12.030_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00439-008-0488-6","article-title":"IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein","volume":"123","author":"Rogus","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacc.2013.12.030_bib11","doi-asserted-by":"crossref","first-page":"e36829","DOI":"10.1371\/journal.pone.0036829","article-title":"Single nucleotide polymorphisms in IL1B and the risk of acute coronary syndrome: a Danish case-cohort study","volume":"7","author":"Stegger","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2013.12.030_bib12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1160\/TH11-06-0377","article-title":"Haplotypes and haplotype-pairs of IL-1 beta and IL-6 genes and risk of non fatal myocardial infarction in the Western New York Acute MI Study","volume":"106","author":"de Gaetano","year":"2011","journal-title":"Thromb Haem"},{"key":"10.1016\/j.jacc.2013.12.030_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.imlet.2010.08.003","article-title":"Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans","volume":"133","author":"Fragoso","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jacc.2013.12.030_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2008.06.029","article-title":"Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction","volume":"203","author":"van Minkelen","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2013.12.030_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/08820130902766142","article-title":"Interleukin 1 gene cluster, myocardial infarction at young age and inflammatory response of human mononuclear cells","volume":"38","author":"Latella","year":"2009","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jacc.2013.12.030_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2007.09.031","article-title":"Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke","volume":"198","author":"Bis","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2013.12.030_bib17","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1253\/circj.CJ-08-1150","article-title":"A\u00a0functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis","volume":"73","author":"Olofsson","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2013.12.030_bib18","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/01.CIR.0000125700.33637.B1","article-title":"Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors","volume":"109","author":"Waehre","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.12.030_bib19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.ATV.16.8.1000","article-title":"Interleukin-1 beta in coronary arteries of patients with ischemic heart disease","volume":"16","author":"Galea","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2013.12.030_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/01.CIR.99.7.861","article-title":"Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease","volume":"99","author":"Francis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.12.030_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cyto.2012.02.012","article-title":"Single nucleotide polymorphisms (SNPs) of pro-inflammatory\/anti-inflammatory and thrombotic\/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype","volume":"58","author":"Tuttolomondo","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.jacc.2013.12.030_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0169-328X(03)00179-7","article-title":"Association of interleukin-1 alpha gene polymorphism with cerebral infarction","volume":"115","author":"Um","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jacc.2013.12.030_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000087928","article-title":"Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease","volume":"20","author":"Dziedzic","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jacc.2013.12.030_bib24","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0735-1097(00)01014-7","article-title":"Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting","volume":"36","author":"Kastrati","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.12.030_bib25","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/ATVBAHA.107.140384","article-title":"Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis","volume":"27","author":"van Minkelen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2013.12.030_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1 beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.12.030_bib27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/CIRCRESAHA.111.256859","article-title":"Role of phospholipid oxidation products in atherosclerosis","volume":"111","author":"Lee","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2013.12.030_bib28","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1194\/jlr.P030890","article-title":"Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions","volume":"53","author":"van Dijk","year":"2012","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2013.12.030_bib29","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.jacc.2013.02.047","article-title":"Oxidation-specific biomarkers and risk of peripheral artery disease","volume":"61","author":"Bertoia","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.12.030_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0735-1097(02)02769-9","article-title":"Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes","volume":"41","author":"Tsimikas","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.12.030_bib31","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1161\/01.CIR.0000130844.01174.55","article-title":"Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein","volume":"109","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.12.030_bib32","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/ATVBAHA.107.145805","article-title":"Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study","volume":"27","author":"Kiechl","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2013.12.030_bib33","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jacc.2012.08.979","article-title":"Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.12.030_bib34","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jacc.2010.04.048","article-title":"Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events","volume":"56","author":"Tsimikas","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.12.030_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/bmm.11.60","article-title":"Oxidized phospholipids on apolipoprotein B-100 (OxPL\/apoB) containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events","volume":"5","author":"Taleb","year":"2011","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.jacc.2013.12.030_bib36","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jacc.2011.12.033","article-title":"Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction","volume":"59","author":"Leibundgut","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.12.030_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.12.030_bib38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/hmg\/1.6.450","article-title":"Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta)","volume":"1","author":"di Giovine","year":"1992","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacc.2013.12.030_bib39","unstructured":"Francis SE, Crossman DC, Duff GW, Kornman KS, Stephenson K, inventors. Diagnostics for cardiovascular disorders. U.S. patent 6,524,795. February 25,\u00a02003."},{"key":"10.1016\/j.jacc.2013.12.030_bib40","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1177\/00220345000790110801","article-title":"Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1 alpha protein in gingival crevicular fluid of teeth with severe periodontal disease","volume":"79","author":"Shirodaria","year":"2000","journal-title":"J\u00a0Dent Res"},{"key":"10.1016\/j.jacc.2013.12.030_bib41","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K","article-title":"IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes","volume":"28","author":"Hurme","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jacc.2013.12.030_bib42","doi-asserted-by":"crossref","first-page":"475S","DOI":"10.1093\/ajcn\/83.2.475S","article-title":"Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging","volume":"83","author":"Kornman","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2013.12.030_bib43","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1054\/bjoc.2000.1479","article-title":"A\u00a0polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer","volume":"83","author":"Barber","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jacc.2013.12.030_bib44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.atherosclerosis.2004.10.036","article-title":"C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus","volume":"179","author":"D'Aiuto","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2013.12.030_bib45","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/00365520510012299","article-title":"Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori cagA genotype","volume":"40","author":"Vilaichone","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jacc.2013.12.030_bib46","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1053\/gast.2002.37043","article-title":"Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection","volume":"123","author":"Hwang","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacc.2013.12.030_bib47","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.4049\/jimmunol.1002402","article-title":"The IL1RN promoter rs4251961 correlates with IL-1 receptor antagonist concentrations in human infection and is differentially regulated by GATA-1","volume":"186","author":"Carrol","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jacc.2013.12.030_bib48","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.gene.6364393","article-title":"Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels","volume":"8","author":"Rafiq","year":"2007","journal-title":"Genes Immun"},{"key":"10.1016\/j.jacc.2013.12.030_bib49","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/STROKEAHA.111.647446","article-title":"Genetic variation within the interleukin-1 gene cluster and ischemic stroke","volume":"43","author":"Olsson","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2013.12.030_bib50","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.ATV.20.11.2394","article-title":"Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis","volume":"20","author":"Dewberry","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2013.12.030_bib51","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.lfs.2012.05.004","article-title":"A\u00a0polymorphism in the upstream regulatory region of the interleukin-1alpha gene confers differential binding by transcription factors of the AP-1 family","volume":"90","author":"Moerman-Herzog","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.jacc.2013.12.030_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.191.2.303","article-title":"Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene","volume":"191","author":"Nicklin","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jacc.2013.12.030_bib53","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1161\/CIRCULATIONAHA.104.519132","article-title":"Elastic-vessel arteritis in interleukin-1 receptor antagonist-deficient mice involves effector Th1 cells and requires interleukin-1 receptor","volume":"111","author":"Shepherd","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.12.030_bib54","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2013.12.030_bib55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.97.3.242","article-title":"Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice","volume":"97","author":"Elhage","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.12.030_bib56","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/01.ATV.0000127025.48140.a3","article-title":"Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice","volume":"24","author":"Isoda","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2013.12.030_bib57","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1161\/CIRCULATIONAHA.107.731877","article-title":"Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis","volume":"117","author":"Ikonomidis","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.12.030_bib58","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.febslet.2005.12.102","article-title":"Cholesterol loading augments oxidative stress in macrophages","volume":"580","author":"Hung","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jacc.2013.12.030_bib59","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/01.ATV.0000208185.16371.97","article-title":"Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli","volume":"26","author":"Deng","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2013.12.030_bib60","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1161\/CIRCRESAHA.111.241869","article-title":"Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1","volume":"109","author":"Romanoski","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2013.12.030_bib61","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.freeradbiomed.2011.08.026","article-title":"Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2","volume":"51","author":"Kadl","year":"2011","journal-title":"Free Rad Biol Med"},{"key":"10.1016\/j.jacc.2013.12.030_bib62","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1074\/jbc.M107602200","article-title":"Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta","volume":"277","author":"Subbanagounder","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2013.12.030_bib63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/cs1030303","article-title":"Genetic variation at the interleukin-1 locus is a determinant of changes in soluble endothelial factors in patients with acute coronary syndromes","volume":"103","author":"Ray","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2013.12.030_bib64","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00439-008-0540-6","article-title":"Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population","volume":"124","author":"Carter","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacc.2013.12.030_bib65","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1194\/jlr.M040733","article-title":"Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)","volume":"54","author":"Leibundgut","year":"2013","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2013.12.030_bib66","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1073\/pnas.90.4.1369","article-title":"5\u2032 control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family","volume":"90","author":"Wade","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2013.12.030_bib67","doi-asserted-by":"crossref","first-page":"e24719","DOI":"10.1371\/journal.pone.0024719","article-title":"Association between the interleukin-6 promoter polymorphism -174G\/C and serum lipoprotein(a) concentrations in humans","volume":"6","author":"Berthold","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2013.12.030_bib68","doi-asserted-by":"crossref","first-page":"e14328","DOI":"10.1371\/journal.pone.0014328","article-title":"Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases","volume":"5","author":"Schultz","year":"2010","journal-title":"PLoS One"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714003325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714003325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:09:09Z","timestamp":1760015349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714003325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":68,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0735109714003325"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2013.12.030","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-Inflammatory Interleukin-1 Genotypes Potentiate the Risk of Coronary Artery Disease and Cardiovascular Events Mediated by Oxidized Phospholipids and Lipoprotein(a)","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2013.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}